Global Cell Culture Market to Reach US$11.3 bn by 2022 due to Rising Demand in Stem Cell, Cancer Research
Fragment-based drug discovery has been recognized as a potential method to design novel molecules as this technique discovery utilizes comparatively small libraries of ‘fragments or ligands’ that are of low-molecular weights. Factors such as less time-consumption and easy access to biophysical fragment screening techniques are driving the growth of the global fragment-based drug discovery market. However, certain factors such as lower level of potency in few compounds derived from fragment screening and requirement of unique ‘fragment libraries’ for performing the studies might pull back the growth of fragment-based drug discovery market.
Request a Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405
The global cell culture market is undergoing significant transition in terms of product differentiation and new product launches in various market segments such as consumables and instruments. The cell culture market was valued at USD 6,097.0 million in 2013 and is projected to reach USD 11,314.5 million by 2022, expanding at a CAGR of 7.1% from 2014 to 2022. Increasing application areas of cell culture technology in cancer detection, drug discovery and manufacturing of biologics have triggered the growth of this market. In addition, utilization of cell culture in various applications such as developing model systems for research, studies of cellular structures and functions, stem cell research and genetic engineering. Furthermore, huge investment in research and development by life science companies, extensive academic and industry collaborations and innovation in stem cell research have also driven the global cell culture market. Use of cell and tissue culture as model systems for studying cellular mechanisms related to various diseases such as diabetes, Parkinson’s and Alzheimer’s, and evaluating drug response is one of the most promising applications of this technology.
Rising manufacture of biologics, such as vaccines and antibodies, is a major driver for the global cell culture market. The preventive effect of these products is highly in demand among patients, leading to steady demand from the cell culture market. Cancer research is another segment generating steady demand from the global cell culture market, due to the high prevalence of various types of cancer around the world.
The emerging field of stem cell research holds promise for the global cell culture market. Stem cells have potential therapeutic application in a wide variety of diseases, making them integral in today’s medical research landscape. Artificial organs have also risen in demand in recent years, as the technology to create the same has become more reliable and effective, making replacement of organs a much simpler task than a few years ago. This is another promising avenue for the global cell culture market, according to the TMR report. These two sectors are also boosted by the high investment made by government as well as private medical organizations.
Browse report: http://www.transparencymarketresearch.com/pressrelease/cell-culture-market.htm
Request a Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405
The global cell culture market is undergoing significant transition in terms of product differentiation and new product launches in various market segments such as consumables and instruments. The cell culture market was valued at USD 6,097.0 million in 2013 and is projected to reach USD 11,314.5 million by 2022, expanding at a CAGR of 7.1% from 2014 to 2022. Increasing application areas of cell culture technology in cancer detection, drug discovery and manufacturing of biologics have triggered the growth of this market. In addition, utilization of cell culture in various applications such as developing model systems for research, studies of cellular structures and functions, stem cell research and genetic engineering. Furthermore, huge investment in research and development by life science companies, extensive academic and industry collaborations and innovation in stem cell research have also driven the global cell culture market. Use of cell and tissue culture as model systems for studying cellular mechanisms related to various diseases such as diabetes, Parkinson’s and Alzheimer’s, and evaluating drug response is one of the most promising applications of this technology.
Rising manufacture of biologics, such as vaccines and antibodies, is a major driver for the global cell culture market. The preventive effect of these products is highly in demand among patients, leading to steady demand from the cell culture market. Cancer research is another segment generating steady demand from the global cell culture market, due to the high prevalence of various types of cancer around the world.
The emerging field of stem cell research holds promise for the global cell culture market. Stem cells have potential therapeutic application in a wide variety of diseases, making them integral in today’s medical research landscape. Artificial organs have also risen in demand in recent years, as the technology to create the same has become more reliable and effective, making replacement of organs a much simpler task than a few years ago. This is another promising avenue for the global cell culture market, according to the TMR report. These two sectors are also boosted by the high investment made by government as well as private medical organizations.
Browse report: http://www.transparencymarketresearch.com/pressrelease/cell-culture-market.htm